课题基金 / 基金详情

Revised Milestone 1 for Grant Reference BB/M013278/1

Revised Milestone 1 for Grant Reference BB/M013278/1
修订拨款参考 BB/M013278/1 的里程碑 1
批准号:
BB/N013522/1
负责人:
Bart Vanhaesebroeck
金额:
$5.05万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Bart Vanhaesebroeck的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41598-018-32389-z
发表时间: 2018-09-20
期刊: Scientific reports
影响因子: 4.6
作者: [Grieco G, Janssens V, Gaide Chevronnay HP, N'Kuli F, Van Der Smissen P, Wang T, Shan J, Vainio S, Bilanges B, Jouret F, Vanhaesebroeck B, Pierreux CE, Courtoy PJ]
通讯作者: Courtoy PJ
DOI: 10.1038/s41467-017-01969-4
发表时间: 2017-11-27
期刊: Nature communications
影响因子: 16.6
作者: [Bilanges B, Alliouachene S, Pearce W, Morelli D, Szabadkai G, Chung YL, Chicanne G, Valet C, Hill JM, Voshol PJ, Collinson L, Peddie C, Ali K, Ghazaly E, Rajeeve V, Trichas G, Srinivas S, Chaussade C, Salamon RS, Backer JM, Scudamore CL, Whitehead MA, Keaney EP, Murphy LO, Semple RK, Payrastre B, Tooze SA, Vanhaesebroeck B]
通讯作者: Vanhaesebroeck B
Integration of lipid and protein kinase signalling in primary cilia biology
  • 批准号:
    BB/W007460/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.23万
  • 财政年份:
    2022
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
  • 批准号:
    MC_PC_MR/S02607X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $7.55万
  • 财政年份:
    2019
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation
  • 批准号:
    BB/R017972/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.47万
  • 财政年份:
    2018
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
  • 批准号:
    BB/M013278/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $15.7万
  • 财政年份:
    2016
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
海外基金